[Successful resuscitation of a patient with hyperkalemic cardiac arrest by emergency hemodiafiltration].
The combination of spironolactone with an ACE inhibitor for patients with heart failure may cause severe hyperkalemia. We report the case of a female patient, who developed hyperkalemic (11.4 mmol/l) cardiac arrest probably induced by combined spironolactone and ACE-inhibitor therapy. She was treated successfully by hemodiafiltration under on-going resuscitation which resulted in restoration of spontaneous circulation within 30 min of starting CPR. She was discharged 2 weeks later without any residual neurological effects.
Gütlich
D
D
Zentrale Abteilung für Anästhesie und Perioperative Medizin, Asklepios Kliniken, Langen/Seligenstadt. Guetlich@gmx.de
Hochscherf
M
M
Hopf
H-B
HB
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D002303:Cardiac Output, Low / Q000503:physiopathology; D016887:Cardiopulmonary Resuscitation; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D004232:Diuretics / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006323:Heart Arrest / Q000150:complications / Q000628:therapy*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D017583:Hemodiafiltration; D006801:Humans; D006947:Hyperkalemia / Q000150:complications / Q000628:therapy*; D006973:Hypertension / Q000150:complications; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D013148:Spironolactone